Some medicines help chemotherapy drugs work better. That’s also true if your cancer comes back (called a relapse), or if your current treatment doesn’t help you enough or stops working (called “refractory” multiple myeloma). Your doctor may combine chemo with drugs: Corticosteroids (steroids...
Multiple myeloma: Chemotherapy or transplantation in the era of new drugs. Eur J Haematol 2010;84:379-90.Palumbo, A.and Rajkumar, SV. (2010): Multiple myeloma: chemotherapy or transplantation in the era of new drugs. Eur. J Haematol., 84: 379- 390....
If you don't have symptoms, your doctor might start you on one of these drugs to keep myeloma from getting worse. Proteasome inhibitors stop the process that eats up extra proteins in cells. Myeloma cells make lots of proteins. When they build up, the cancer cells die. These drugs include...
Chemo drugs for Myeloma Description Uses of Lenalid (Lenalidomide) Capsule Multiple Myeloma Lenalid (Lenalidomide) is the generic name of the Revlimid. It used to treat Multiple Myeloma with the combination of dexamethasone. Myelodysplastic syndrome This medication is also used in the treatment of...
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive myeloma: predictors of complete remission Bone Marrow Transplant, 33 (2004), pp. 61-64 CrossrefView in ScopusGoogle Scholar 18. J.J. Lahuerta, M.V. Mateos, J. Martínez-López, et al. Influence of pre- ...
Multiple myeloma (MM) is the second most common hematologic malignancy after non-Hodgkin’s lymphoma. Intrinsic and acquired drug resistance of cancer cells to standard drugs is a major obstacle for a more successful survival outcome of MM patients treated on contemporary clinical protocols. The prim...
Multiple myeloma (MM) is an osteolytic malignancy that is incurable due to the emergence of treatment resistant disease. Defining how, when and where myeloma cell intrinsic and extrinsic bone microenvironmental mechanisms cause relapse is challenging wit
Multiple myeloma (MM) is a cancer of mature plasma cells, which are a type of white blood cell that produces immunoglobulins (antibodies). Antibodies are normally produced to protect the body from microbes, such as bacteria. In multiple myeloma, the monoclonal plasma cells produce a monoclonal ...
Abstract: Multiple myeloma (MM) is the second most frequent hematological malignancy characterized by bone marrow aberrant plasma cells proliferation leading to a genetic complex and heterogeneous disease, with a median survival ranging from two to more than 10 years. By using new drug...
Multiple myeloma (MM) is a hematological cancer characterized by the abnormal proliferation of plasma cells. Initial treatments often include immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies (mAbs). Despite salient p